Delivery Order SPE2DR25D3004-SPE2DR26FXRY4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Naloxone HCL 4 mg nasal spray in two-spray units, with a contract ceiling value of $6,605.18. This is a firm fixed-price delivery order executed without set-aside provisions, indicating competitive award to a qualified vendor. The performance location is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and the delivery deadline is set for...
- The Defense Logistics Agency awarded a delivery order valued at $9,093.31 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal military...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.88 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $8,699.87. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by June 3, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Naloxone is a critical opioid...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.47 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on November 7, 2025, with completion targeted for November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 14, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-count packages) with a contract ceiling value of $3,013.92. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Naloxone HCL 4 mg nasal spray in a quantity of 2 units. This contract is valued at $1,135.68 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-spray units) on November 10, 2025, with a ceiling value of approximately $12,000 and an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.79 to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-spray units). The contract carries a firm fixed price and is scheduled for completion by December 12, 2025, with performance to take place at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXRY4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Naloxone HCL 4 mg nasal spray (2-pack units) with a contract ceiling value of $4,046.05 and a completion date of December 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime indefinite delivery vehicle serves as a global pharmaceutical support contract enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs and other federal government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Naloxone, an opioid antagonist used in emergency medical settings, represents part of the critical medical commodities portfolio available through this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/29/25 |